Clinical Trial Update: Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an mRNA vaccine in liver transplantation for hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• mRNA vaccine

Snippet

Sponsor: West China Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: RECRUITING